Amundi Asset Management US’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $75.1M | Buy |
266,377
+26,715
| +11% | +$7.53M | 0.06% | 328 |
|
2020
Q4 | $67.9M | Buy |
239,662
+463
| +0.2% | +$131K | 0.06% | 324 |
|
2020
Q3 | $65.8M | Buy |
239,199
+28,408
| +13% | +$7.81M | 0.07% | 279 |
|
2020
Q2 | $47.9M | Buy |
210,791
+54,596
| +35% | +$12.4M | 0.06% | 316 |
|
2020
Q1 | $23.8M | Buy |
156,195
+14,771
| +10% | +$2.25M | 0.04% | 368 |
|
2019
Q4 | $21.3M | Sell |
141,424
-10,618
| -7% | -$1.6M | 0.02% | 540 |
|
2019
Q3 | $21.6M | Buy |
152,042
+4,706
| +3% | +$667K | 0.03% | 488 |
|
2019
Q2 | $41.1M | Buy |
147,336
+115,162
| +358% | +$32.1M | 0.03% | 374 |
|
2019
Q1 | $3.55M | Sell |
32,174
-24,944
| -44% | -$2.75M | 0.01% | 963 |
|
2018
Q4 | $5.6K | Sell |
57,118
-4,936
| -8% | -$484 | 0.01% | 807 |
|
2018
Q3 | $7.66M | Buy |
62,054
+53,365
| +614% | +$6.59M | 0.01% | 800 |
|
2018
Q2 | $863K | Sell |
8,689
-33,575
| -79% | -$3.33M | ﹤0.01% | 1276 |
|
2018
Q1 | $3.73M | Buy |
42,264
+1,125
| +3% | +$99.3K | 0.01% | 926 |
|
2017
Q4 | $4.06M | Buy |
+41,139
| New | +$4.06M | 0.01% | 895 |
|